Therefore, in our study, we conducted a pan-cancer analysis of FDX1 in different cancers based on the data from the most comprehensive databases and also explored the effect of FDX1 in BLCA, ccRCC, and PCa cells for the first time. Here, FDX1 is linked to bladder transitional cell carcinoma.